Matches in SemOpenAlex for { <https://semopenalex.org/work/W61504295> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- W61504295 endingPage "6" @default.
- W61504295 startingPage "43" @default.
- W61504295 abstract "Caution is called for in providing family planning counseling and contraceptive prescriptions for women with hematological disorders. Iron deficiency anemia is a common problem among women of reproductive age. During menstruation women's need for iron intake is 3 times that of men. Oral contraceptives (OCs) are an appropriate contraceptive choice for iron deficiency anemia patients since OCs are associated with reduced blood loss during menstruation. Most IUDs, and especially unmedicated and copper bearing devices, should not be used by women with iron deficiency anemia. Progestin releasing IUDs tend to increase hemoglobin and serum ferritin levels, therefore, patients with iron deficiency anemia may benefit from progestin releasing IUD insertions. Women with hemorrhagic disorders, such as hemophilia, purpuras, and platelet number and function disorders frequently experience menorrhagia. OCs are an appropriate contraceptive for many patients with these disorders. Several studies indicate that patients with hemorrhagic disorders frequently experience reduced bleeding problems when they use OCs. IUDs are contraindicated for women with hemorrhagic diseases because IUDs may increase blood loss. Women with sickle cell hemoglobinopathies need careful counseling. Pregnancy for these women entails high morbidity and mortality risks. Series data shows that pregnant women with sickle cell hemoglobinopathies have a 4%-100% risk of maternal morbidity and a 1%-35% risk of maternal mortality. The risk of maternal morbidity and mortality is equally high for women with hemoglogin sickle cell disease but somewhat lower for women with sickle cell thalassemia. Women with these diseases should be informed about the risks associated with pregnancy. These patients may want to consider sterilization. Oral and IUD contraceptives are contraindicated for patients with these disorders; the former, because it may have a thromboembolic effect, and the latter, because it is associated with high blood loss. There are some reports that progesterone protects against sickling, but more intensive studies must be undertaken before progesterone can be recommended for women with sickle cess disorders. If patients insist on using an OC, a minipill may be prescribed. Barrier methods are probably the best choice for sickle cell disorder patients." @default.
- W61504295 created "2016-06-24" @default.
- W61504295 creator A5028503679 @default.
- W61504295 date "1985-03-01" @default.
- W61504295 modified "2023-10-18" @default.
- W61504295 title "Patients with hematologic disorders need careful birth control counseling." @default.
- W61504295 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12266720" @default.
- W61504295 hasPublicationYear "1985" @default.
- W61504295 type Work @default.
- W61504295 sameAs 61504295 @default.
- W61504295 citedByCount "0" @default.
- W61504295 crossrefType "journal-article" @default.
- W61504295 hasAuthorship W61504295A5028503679 @default.
- W61504295 hasConcept C126322002 @default.
- W61504295 hasConcept C131872663 @default.
- W61504295 hasConcept C187212893 @default.
- W61504295 hasConcept C2777799968 @default.
- W61504295 hasConcept C2778248108 @default.
- W61504295 hasConcept C2779076696 @default.
- W61504295 hasConcept C2779234561 @default.
- W61504295 hasConcept C2779771394 @default.
- W61504295 hasConcept C2908647359 @default.
- W61504295 hasConcept C29456083 @default.
- W61504295 hasConcept C2986817661 @default.
- W61504295 hasConcept C54355233 @default.
- W61504295 hasConcept C71924100 @default.
- W61504295 hasConcept C86803240 @default.
- W61504295 hasConcept C99454951 @default.
- W61504295 hasConceptScore W61504295C126322002 @default.
- W61504295 hasConceptScore W61504295C131872663 @default.
- W61504295 hasConceptScore W61504295C187212893 @default.
- W61504295 hasConceptScore W61504295C2777799968 @default.
- W61504295 hasConceptScore W61504295C2778248108 @default.
- W61504295 hasConceptScore W61504295C2779076696 @default.
- W61504295 hasConceptScore W61504295C2779234561 @default.
- W61504295 hasConceptScore W61504295C2779771394 @default.
- W61504295 hasConceptScore W61504295C2908647359 @default.
- W61504295 hasConceptScore W61504295C29456083 @default.
- W61504295 hasConceptScore W61504295C2986817661 @default.
- W61504295 hasConceptScore W61504295C54355233 @default.
- W61504295 hasConceptScore W61504295C71924100 @default.
- W61504295 hasConceptScore W61504295C86803240 @default.
- W61504295 hasConceptScore W61504295C99454951 @default.
- W61504295 hasIssue "3" @default.
- W61504295 hasLocation W615042951 @default.
- W61504295 hasOpenAccess W61504295 @default.
- W61504295 hasPrimaryLocation W615042951 @default.
- W61504295 hasRelatedWork W1992255620 @default.
- W61504295 hasRelatedWork W2010733380 @default.
- W61504295 hasRelatedWork W2135006703 @default.
- W61504295 hasRelatedWork W2278210300 @default.
- W61504295 hasRelatedWork W2349042507 @default.
- W61504295 hasRelatedWork W2383769626 @default.
- W61504295 hasRelatedWork W2388328511 @default.
- W61504295 hasRelatedWork W2908607191 @default.
- W61504295 hasRelatedWork W3157172621 @default.
- W61504295 hasRelatedWork W61504295 @default.
- W61504295 hasVolume "6" @default.
- W61504295 isParatext "false" @default.
- W61504295 isRetracted "false" @default.
- W61504295 magId "61504295" @default.
- W61504295 workType "article" @default.